How to manage individualized drug therapy: application of pharmacogenetic knowledge of drug metabolism and transport. (Q34093093)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11097342%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

review article

1 reference

title

How to manage individualized drug therapy: application of pharmacogenetic knowledge of drug metabolism and transport (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11097342%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11097342%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

C Meisel

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11097342%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

I Roots

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11097342%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

U Brinkmann

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11097342%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

J Brockmöller

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11097342%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 September 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11097342%20AND%20SRC:MED&resulttype=core&format=json

Clinical Chemistry and Laboratory Medicine

2 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11097342%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11097342%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11097342%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

869-876

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11097342%20AND%20SRC:MED&resulttype=core&format=json

Frequency and cost of serious adverse drug reactions in a department of general medicine

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.126

Counting the costs of drug-related adverse events

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.126

Molecular basis of polymorphic drug metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.126

Inherited amplification of an active gene in the cytochrome P450 CYP2D locus as a cause of ultrarapid metabolism of debrisoquine

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.126

Use of in vitro and in vivo data to estimate the likelihood of metabolic pharmacokinetic interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.126

Impact of environmental and genetic factors on codeine analgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.126

Human thiopurine methyltransferase pharmacogenetics: Gene sequence polymorphisms*

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.126

Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.126

Choroid plexus epithelial expression of MDR1 P glycoprotein and multidrug resistance-associated protein contribute to the blood-cerebrospinal-fluid drug-permeability barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.126

Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.126

The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.126

The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.126

Biochemical, cellular, and pharmacological aspects of the multidrug transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.126

Pharmacogenetic diagnostics of cytochrome P450 polymorphisms in clinical drug development and in drug treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.126

Correlation between genotype and phenotype of the human arylamine N-acetyltransferase type 1 (NAT1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.126

Arylamine N-acetyltransferase activity in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.126

Polymorphic human cytochrome P450 enzymes: an opportunity for individualized drug treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.126

Frequency of cytochrome P450 CYP2C9 variants in a Turkish population and functional relevance for phenytoin

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.126

Flavin monooxygenase 3 (FMO3) polymorphism in a white population: allele frequencies, mutation linkage, and functional effects on clozapine and caffeine metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.126

Genetic polymorphism of human liver alcohol and aldehyde dehydrogenases, and their relationship to alcohol metabolism and alcoholism

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.126

Methylation pharmacogenetics: catechol O-methyltransferase, thiopurine methyltransferase, and histamine N-methyltransferase

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.126

Genetic polymorphisms of human N-acetyltransferase, cytochrome P450, glutathione-S-transferase, and epoxide hydrolase enzymes: relevance to xenobiotic metabolism and toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.126

Ethnic variation in the prevalence of a common NAD(P)H quinone oxidoreductase polymorphism and its implications for anti-cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.126

Pharmacogenetics of sulfotransferase

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.126

Diagnostic analysis, clinical importance and molecular basis of dihydropyrimidine dehydrogenase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.126

Pharmacokinetics of N-propylajmaline in relation to polymorphic sparteine oxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.126

21 January 2018

Identifiers

DOI

10.1515/CCLM.2000.126

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11097342%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11097342%20AND%20SRC:MED&resulttype=core&format=json